HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1).

Abstract
Lithium remains the most widely used long-term treatment for bipolar affective disorder, but the molecular mechanisms underlying its therapeutic efficacy have not been fully elucidated. Two enzymes involved in the phospholipase C signalling system, namely the myo-inositol monophosphatase (IMPase) and the inositol polyphosphate 1-phosphatase (IPPase), have been postulated as targets for the therapeutic action of lithium in manic-depressive illness. Intriguingly, Drosophila mutants lacking IPPase activity display a defect in synaptic transmission, and this alteration could be phenocopied by lithium exposure. We recently demonstrated the presence of several polymorphisms in the IPPase-encoding inositol polyphosphate 1-phosphatase gene (INPP1) cDNA and suggested that polymorphic variants of the human IPPase might be associated with the striking difference in lithium response among bipolar patients. We report the genomic structure and organization of the INPP1 gene on chromosome 2q32. Based on DNA sequencing of the entire genomic region containing INPP1, we found that the gene consists of six exons and spans more than 25 kb. Expression analysis showed that INPP1 is present as a 1.9 kb mRNA transcript in all organs and tissues examined, including the central nervous system. The level of expression varies, with at least a fourfold higher transcript level in testis compared with other tissues with high expression. A highly polymorphic dinucleotide repeat, (CA)18-25, with an observed heterozygosity of 0.86 was detected immediately downstream of the gene. The present sequence information will be used to further investigate the possible role of the INPP1 gene in lithium-treated bipolar illness.
AuthorsR Løvlie, A K Gulbrandsen, A Molven, V M Steen
JournalPharmacogenetics (Pharmacogenetics) Vol. 9 Issue 4 Pg. 517-28 (Aug 1999) ISSN: 0960-314X [Print] England
PMID10780272 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • DNA, Complementary
  • RNA, Messenger
  • Lithium
  • Phosphoric Monoester Hydrolases
  • inositol-1,4-bisphosphate 1-phosphatase
Topics
  • Animals
  • Base Sequence
  • Bipolar Disorder (drug therapy)
  • Chromosomes, Human, Pair 2
  • DNA Primers
  • DNA, Complementary
  • Exons
  • Humans
  • Lithium (therapeutic use)
  • Mice
  • Phosphoric Monoester Hydrolases (genetics)
  • Polymorphism, Genetic
  • Promoter Regions, Genetic
  • RNA, Messenger (genetics)
  • Repetitive Sequences, Nucleic Acid
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: